Patient characteristics and incidence (number and percentage) of infective pneumonia adverse events associated with TNF-α inhibitors.

Patient characteristics and incidence (number and percentage) of infective pneumonia adverse events associated with TNF-α inhibitors.

<p>Patient characteristics and incidence (number and percentage) of infective pneumonia adverse events associated with TNF-α inhibitors.</p>

Saved in:

Bibliographic Details
Main Author:	Qinhui Tang (21989425) (author)
Other Authors:	Xiaowei Tang (410415) (author), Wenmeng Yin (21989428) (author), Yantong Li (21989431) (author), Xiaolin Zhong (10158980) (author)
Published:	2025
Subjects:	Medicine Microbiology Genetics Molecular Biology Pharmacology Biotechnology Immunology Cancer Infectious Diseases Virology Chemical Sciences not elsewhere classified Information Systems not elsewhere classified world disproportionality analysis tnf -&# 945 article primarily explores removing duplicate reports xlink "> except pneumocystis jirovecii pneumonia two positive signals seven positive signals whereas certolizumab pegol infective pneumonia following infective pneumonia associated database </ p xlink "> patients related adverse events xlink "> positive signals certolizumab pegol adverse events infective pneumonia show signals extracting reports 7176 reports pneumonia legionella pneumonia klebsiella pneumonia cryptococcal pneumonia bacterial including pneumonia 19 pneumonia us food tuberculous pleurisy totaling 10 tnfis ). related diseases market launch highest incidence help reduce healthcare professionals first quarter faers database drug administration collected data clinical trials bronchopulmonary aspergillosis 819 cases 202 cases
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	<p>Patient characteristics and incidence (number and percentage) of infective pneumonia adverse events associated with TNF-α inhibitors.</p>

Cannot write session to /tmp/vufind_sessions/sess_fr7sbdscsenu4b2vkk0qj8qteo